Best Tumor marker CA-125 Doctors Worldwide — TOP 16

Dr. Solak trained at the MD Anderson Cancer Center in the USA. He specializes in monitoring gynecological malignancies like ovarian cancer at Hisar Hospital.

• Completed an advanced fellowship at the prestigious Hacettepe University Cancer Institute
• Specializes in evaluating CA-125 markers to monitor ovarian cancer treatment progress
• Expert in biological therapies and immunotherapy for advanced solid tumors
• Coordinates systemic cancer care including chemotherapy and modern targeted treatments
• Member of the oncology team at the JCI-accredited Hisar Hospital Intercontinental

Dr. Suleyman Hilmi Aksoy serves as an Assistant Professor at Cerrahpasa Medical Faculty. He is a senior radiology specialist at Hisar Hospital Intercontinental.

• Specializes in interventional radiology to guide tumor marker CA-125 evaluations
• Expertise in whole-body CT and MRI for tumor detection
• Presented research at 13 national and international medical congresses
• Member of the European Society of Radiology (ESR)
• Certified in radiodiagnostics from Istanbul University

Dr. Tahsin Ozatli is an oncology specialist at Istinye University Hospital. He uses tumor marker CA-125 results to monitor and treat gastrointestinal cancers.

• Promoted to Associate Professor – a senior rank for academic and clinical expertise
• Former physician at the Ankara Oncology Clinic in Turkey
• Served at the Erzurum Regional Training and Research Hospital
• Specializes in treating lung and breast cancer cases
• Trained at the Selcuk University Faculty of Medicine

Dr. Elnur Sahibov is a radiation oncology specialist at Emsey Hospital. He uses his expertise in cancer diagnostics to evaluate tumor marker CA-125 results.

• Completed specialization at Marmara University Department of Radiation Oncology
• Studied medicine at Marmara University Faculty of Medicine
• Focuses on oncologic imaging and tumor monitoring
• Member of the oncology team at the JCI-accredited Emsey Hospital

Dr. Shruti Kate heads the oncology department at HCG Manavata Cancer Centre. She formerly served as a consultant at the world-renowned Tata Memorial Hospital.

• Specializes in gynecological cancers where tumor marker CA-125 is a vital screening tool
• Trained in medical oncology at Tata Memorial Hospital in Mumbai
• Received a prestigious solo travel award for lung cancer research in Toronto
• Member of the American Society of Clinical Oncology (ASCO)
• Belongs to the European Society for Medical Oncology (ESMO)

Dr. Antonio Cubillo Gracián leads the Medical Oncology Service at HM Sanchinarro. He pioneered a Spanish liquid biopsy program for molecular tumor analysis, including marker CA-125 evaluations.

• Director of Postgraduate Research at HM CIOCC USP CEU medical school
• Director of the Master's program in Clinical and Applied Research in Oncology
• Uses molecular markers to design targeted cancer treatment plans
• Co-investigator for the Start Madrid clinical trials program for new therapies
• Associate Professor of Oncology at USP CEU university

Professor Ersin Ozturk is a surgical oncology specialist at Medicana Bursa Hospital. He completed a prestigious colorectal surgery fellowship at the Cleveland Clinic in the USA.

• Heads cases involving tumor marker CA-125 for digestive and pelvic cancers
• Specializes in laparoscopic surgery – uses small incisions for faster recovery
• Ph.D. in physiology helps him interpret complex diagnostic data more accurately
• Member of the Turkish Surgical Association – the national body for surgery
• Performs advanced surgeries for liver, stomach, and pancreatic cancers

Professor Engin is the Director of Oncological Sciences at Medicana Bursa Hospital. He specializes in treating gynecological cancers where tumor marker CA-125 is used for monitoring.

• Completed a post-doctoral fellowship in thermoradiotherapy at Thomas Jefferson University in the USA
• Former Coordinator of Oncological Sciences at Anadolu Medical Center for 13 years
• Specializes in using CyberKnife for robotic radiation with pinpoint accuracy to protect tissue
• Former Chairman of Radiation Oncology at Uludağ University Medical College in Turkey
• Conducted cancer risk research at the National Cancer Institute in Bethesda

Dr. Sridhar P.S. is a radiation oncology expert at HCG Manavata Cancer Centre. He focuses on tumor marker CA-125 for ovarian cancer assessment.

• Holds a Doctorate in radiotherapy from Banaras Hindu University
• Diplomate of the National Board in radiotherapy
• Member of the Association of Radiation Oncology of India
• Member of the Society for Neuro-Oncology
• Participates in the Bangalore Oncology Group to stay updated on cancer care

Dr. Chaitainya Borde has handled over 30,000 PET scans at HCG Manavata Cancer Centre. He is a specialist in nuclear medicine and diagnostic imaging.

• Provides tumor marker CA-125 testing within a specialized nuclear medicine department
• Performs radioiodine and Lu-177 therapies for advanced cancer cases
• Offers nuclear cardiology services to assess heart health during treatment
• Has treated over 1,000 thyroid cancer patients using radioactive iodine therapy
• Author of several research papers published in recognized medical journals

Dr. Ahmer Arif Shaikh is a surgical oncologist at the NABH-accredited HCG Manavata Cancer Centre. He specializes in screening for various cancers, including using tumor marker CA-125 for diagnostic monitoring.

• Fellowship-trained in Head and Neck Surgical Oncology at HCG Manavata Cancer Centre
• Performs lymphadenectomy to check if cancer has spread to the lymph nodes
• Treats complex oncology cases using organ preservation and functional rehabilitation techniques
• Contributes to medical science with research published in national and international journals
• Master of Dental Surgery from Rajasthan University of Health Sciences

10,000 major surgeries performed – Dr. Lalit Banswal is a leading surgical oncologist at HCG Manavata Cancer Centre.

• Specializes in gastrointestinal oncology and complex tumor diagnostic protocols
• Fellowship-trained at Tata Medical Centre, a top institution for cancer care
• Former lead investigator for clinical research in gastrointestinal cancers
• Assistant Professor at the State Cancer Institute and Government Cancer Hospital
• Expert in interpreting CA-125 markers during robotic and laparoscopic cancer surgeries

Dr. Shaunak Valame is a medical oncologist at HCG Manavata Cancer Centre. He focuses on the molecular basis of gynecological cancers where tumor marker CA-125 testing is vital.

• Completed oncology training at Indraprastha Apollo Hospital in New Delhi
• Presented stomach cancer research to the American Society of Clinical Oncology
• Specializes in targeted therapies for solid tumors and gynecological malignancies
• Member of the American Society of Clinical Oncology (ASCO)
• Former lecturer for the International Winter School of Oncology at AIIMS

With 50,000+ cancer surgeries performed, Dr. Nagarkar is a leading surgical oncologist. He uses his vast experience to guide tumor marker CA-125 testing for cancer screening.

• Chief of Surgical Oncology at HCG Manavata Cancer Centre, prioritizing quality of life
• Trained at Tata Memorial Hospital, India's most prestigious cancer research and treatment facility
• Member of the Royal College of Surgeons of Edinburgh, ensuring international clinical standards
• Leads clinical trials to improve cancer detection and surgical outcomes for complex cases
• Professor for DNB Superspecialty Surgical Oncology, training the next generation of cancer surgeons